Edelson J., Benziger DP, Arnold A. & Bayler ALBlood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidaemic agent. Atherosclerosis1979; 30: 351-7.
2.
Schmidt FH, Stegmeier K., Stork H., Endale R. & Koch K.Pharmacokinetics and metabolism of bezafibrate in animals. In L ipoproteins and Coronary Heart Disease, eds H Cretan, P Long & T Schettler, pp. 102-105. G. Gerhard Witzstrock Publishing House, 1980.
3.
Gibaldi M.Biopharmaceuticals and Clinical Pharmacokinetics, pp. 24-27. Philadelphia : Lea and Febiger, 1984.
